Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
NL-OMON25518Not yet recruiting
Open-label trial of acetaminophen in class III obesity (2 arms), sponsored by N/A. Primary endpoint: Pharmacokinetics of paracetamol. Planned start Feb 2020; status: not yet recruiting.
Beyond the preview
Study design, results and competitive context are available in the Gosset platform where reported.
Available in the Gosset platform where reported.
Available in the Gosset platform where reported.
See how Gosset can support your research on NL-OMON25518.